Enhanced Curable Radiopaque Substances for 3D Printing

Publication ID: 24-11857649_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Curable Radiopaque Substances for 3D Printing,” Published Technical Disclosure No. 24-11857649_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857649_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,649.

Summary of the Inventive Concept

This invention introduces a series of direct improvements and enhancements to curable radiopaque substances, enabling faster, safer, and more efficient production of materials with improved optical properties for various applications.

Background and Problem Solved

The original patent disclosed a curable radiopaque substance with limitations in terms of print speed, shelf life, and radiopacity. The present inventive concept addresses these limitations by introducing novel compositions, methods, and systems that enhance the performance of the curable substance in 3D printing applications.

Detailed Description of the Inventive Concept

The new inventive concept comprises four key aspects: (1) a system for producing curable and radiopaque materials using 3D printing devices, (2) a method for enhancing radiopacity by mixing with rare earth compounds and exposing to radiation, (3) a curable substance with improved shelf life due to the addition of a UV stabilizer, and (4) a system for optimizing print speed by adjusting viscosity and printing parameters. These innovations enable the production of materials with improved optical properties, faster print speeds, and enhanced radiopacity.

Novelty and Inventive Step

The new claims introduce novel combinations of compounds, methods, and systems that improve upon the original patent's limitations. Specifically, the use of rare earth compounds, UV stabilizers, and optimized print speed parameters constitutes a non-obvious and innovative step forward in the field of curable radiopaque substances.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different rare earth compounds, varying the concentration of UV stabilizers, or incorporating additional additives to further enhance the performance of the curable substance. Variations may also involve adapting the system and method for use in different 3D printing technologies or applications.

Potential Commercial Applications and Market

The enhanced curable radiopaque substances and related systems and methods have significant commercial potential in the dental, medical, and industrial 3D printing markets, where the demand for high-performance materials with improved optical properties is growing.

CPC Classifications

SectionClassGroup
A A61 A61K6/70
A A61 A61K6/847
A A61 A61K6/887
C C08 C08F220/12

Original Patent Information

Patent NumberUS 11,857,649
TitleCurable radiopaque substance
Assignee(s)Merz Dental GmbH